- 4-Week # shares sold: 2,000
- 12-Week # shares sold: 3,675
- 24-Week # shares sold: 3,675
Investors shouldn't be buying certain healthcare stocks based on Donald Trump's nomination of Tom Price as HHS chief, says Jim Cramer.
Here are Tuesday's top research calls, including upgrades for Brocade and Stryker, and a downgrade for SVB Financial.